Trial
NCT01714817
Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Bristol-Myers Squibb
Collaborators
—
Condition
Lupus Nephritis
Intervention
BMS-188667
Why stopped
Inability to meet protocol objectives.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-02-26